The invention relates to a medicament comprising at least one reducing alkyl-sugar monomer having a hydroxyl function which is substituted by an alkoxy radical at C
2
-C
40
, said medicament being preferably intended to regulate inflammatory mechanisms. The reducing sugar is preferably selected from the group containing rhamnose, fucose and glucose. The invention also relates to a cosmetic treatment method involving the topical application of a composition comprising at least one reducing alkyl-sugar monomer having a hydroxyl function which is substituted by an alkoxy radical at C
2
-C
40
.
该发明涉及一种药物,包括至少一种含有羟基功能的还原烷基糖单体,该羟基功能在C2-C40处被烷氧基取代,所述药物通常用于调节炎症机制。还原糖通常选自包含
鼠李糖、岩藻糖和
葡萄糖的组。该发明还涉及一种化妆品处理方法,涉及局部应用包含至少一种含有羟基功能的还原烷基糖单体,该羟基功能在C2-C40处被烷氧基取代的组合物。